0QCV
AbbVie, Inc. · LSIN:0QCV
294.50 USD4.00 +1.38%
AbbVie, Inc. (LSIN:0QCV) last traded at 294.50 USD, up 1.38% on the day. Over the past year the stock is up 30.45%. Its 52-week range is 190.44 to 306.97. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open294.50
Day range281.00 – 306.97
52-week range190.44 – 306.97
Volume16.96 K
Average volume (10 days)17.23 K
Market cap521.11 B
P/E50.62
EPS (TTM)5.82
Dividend yield2.32%
Beta (1 year)0.5346
Revenue (TTM)66.01 B
Employees57.00 K
Performance
+2.97%1 week
+10.76%1 month
+14.48%3 months
+38.65%6 months
+29.03%Year to date
+30.45%1 year
Technical rating
Strong buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
302.50 USD
The average 1-year price target, +2.72% from the last price. See the forecast
Latest headlines
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
- AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026
- What AbbVie (ABBV) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.